Found: 28
Select item for more details and to access through your institution.
Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for success.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1099, doi. 10.1002/ajh.25909
- By:
- Publication type:
- Article
Limitations of the particle immunofiltration assay test for diagnosis of heparin‐induced thrombocytopenia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E250, doi. 10.1002/ajh.25901
- By:
- Publication type:
- Article
Moderate fixed‐dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E247, doi. 10.1002/ajh.25900
- By:
- Publication type:
- Article
Genetic screens reveal CCDC115 as a modulator of erythroid iron and heme trafficking.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1085, doi. 10.1002/ajh.25899
- By:
- Publication type:
- Article
Ruxolitinib combined with etanercept induce a rapid response to corticosteroid‐refractory severe acute graft vs host disease after allogeneic stem cell transplantation: Results of a multi‐center prospective study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1075, doi. 10.1002/ajh.25898
- By:
- Publication type:
- Article
Outcome of adults with relapsed/refractory T‐cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E245, doi. 10.1002/ajh.25896
- By:
- Publication type:
- Article
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose‐prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E242, doi. 10.1002/ajh.25883
- By:
- Publication type:
- Article
Patient‐reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1066, doi. 10.1002/ajh.25880
- By:
- Publication type:
- Article
Impact of detectable measurable residual disease on umbilical cord blood transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1057, doi. 10.1002/ajh.25879
- By:
- Publication type:
- Article
Risk‐based, response‐adapted therapy for early‐stage extranodal nasal‐type NK/T‐cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1047, doi. 10.1002/ajh.25878
- By:
- Publication type:
- Article
Real‐world effectiveness of eliglustat in treatment‐naïve and switch patients enrolled in the International Collaborative Gaucher Group Gaucher Registry.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1038, doi. 10.1002/ajh.25875
- By:
- Publication type:
- Article
Prognostic impact of Philadelphia chromosome in mixed phenotype acute leukemia (MPAL): A cancer registry analysis on real‐world outcome.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1015, doi. 10.1002/ajh.25873
- By:
- Publication type:
- Article
ABVD vs BEACOPP escalated in advanced‐stage Hodgkin's lymphoma: Results from a multicenter European study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1030, doi. 10.1002/ajh.25871
- By:
- Publication type:
- Article
Laboratory misdiagnosis of von Willebrand disease in post‐menarchal females: A multi‐center study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1022, doi. 10.1002/ajh.25869
- By:
- Publication type:
- Article
Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi‐center HGB‐206 trial.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E239, doi. 10.1002/ajh.25867
- By:
- Publication type:
- Article
Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E235, doi. 10.1002/ajh.25864
- By:
- Publication type:
- Article
Evidence of transfusion‐induced reductions in cerebral capillary shunting in sickle cell disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E228, doi. 10.1002/ajh.25863
- By:
- Publication type:
- Article
A holistic approach to iron chelation therapy in transfusion‐dependent thalassemia patients with serum ferritin below 500 μg/L.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E230, doi. 10.1002/ajh.25860
- By:
- Publication type:
- Article
The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1006, doi. 10.1002/ajh.25859
- By:
- Publication type:
- Article
Phase I/II study of high dose pomalidomide with G‐CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E232, doi. 10.1002/ajh.25858
- By:
- Publication type:
- Article
Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E225, doi. 10.1002/ajh.25854
- By:
- Publication type:
- Article
Thirty‐three years later: Two distinct cases of acute lymphoblastic leukemia in one patient.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1117, doi. 10.1002/ajh.25850
- By:
- Publication type:
- Article
Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E222, doi. 10.1002/ajh.25843
- By:
- Publication type:
- Article
Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E218, doi. 10.1002/ajh.25832
- By:
- Publication type:
- Article
The differential diagnosis of basophilia in patients undergoing BCR‐ABL testing.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E216, doi. 10.1002/ajh.25830
- By:
- Publication type:
- Article
Beta thalassemia major and Noonan syndrome — Two genetic disorders manifest in the blood film.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1113, doi. 10.1002/ajh.25767
- By:
- Publication type:
- Article
Loss of surface CD3 expression in allogeneic CAR T‐cells.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1115, doi. 10.1002/ajh.25775
- By:
- Publication type:
- Article
Issue Information – Table of Contents.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. 1003, doi. 10.1002/ajh.25535
- Publication type:
- Article